Aspira Womens Health Q4 EPS $(0.30) Beats $(0.45) Estimate, Sales $2.13M Miss $2.54M Estimate
Portfolio Pulse from Benzinga Newsdesk
Aspira Womens Health (NASDAQ:AWH) reported Q4 earnings with a loss of $(0.30) per share, surpassing the $(0.45) estimate, marking a 33.33% beat and a 45.45% improvement from last year's $(0.55) loss. However, their $2.13M in sales fell short of the $2.54M estimate by 16.14%, and slightly decreased by 1.07% from last year's $2.15M.
March 28, 2024 | 11:33 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Aspira Womens Health reported a Q4 EPS of $(0.30), beating estimates but with sales missing expectations at $2.13M.
The mixed results with an earnings beat but a miss on sales revenue could lead to uncertain short-term stock price movements for AWH. The better-than-expected loss per share indicates operational efficiency or cost control, which is positive. However, the miss on sales forecasts could raise concerns about growth prospects or market demand, potentially offsetting the positive impact of the earnings beat.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100